ARCHIVES

Zaltrap Receives Positive Opinion For European Market From CHMP

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

No Link Between Pneumonitis, Taxanes, And Radiation

November 26, 2004

Symposium Addresses FCC issues

February 21, 1986

MSK Withdraws Form Breast Cancer Nutrition Study Over Chemotherapy Issue; Program Still “Going Well”

June 21, 1985

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995